These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26925801)

  • 21. N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.
    Jakary A; Vinogradov S; Feiwell R; Deicken RF
    Schizophr Res; 2005 Jul; 76(2-3):173-85. PubMed ID: 15949650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between performance on the Stroop test and N-acetylaspartate in the medial prefrontal cortex in deficit and nondeficit schizophrenia: preliminary results.
    Delamillieure P; Constans JM; Fernandez J; Brazo P; Dollfus S
    Psychiatry Res; 2004 Nov; 132(1):87-9. PubMed ID: 15546706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.
    Bertolino A; Breier A; Callicott JH; Adler C; Mattay VS; Shapiro M; Frank JA; Pickar D; Weinberger DR
    Neuropsychopharmacology; 2000 Feb; 22(2):125-32. PubMed ID: 10649825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo (1)H-MRS study of the Stroop Color-Word task.
    Grachev ID; Kumar R; Ramachandran TS; Szeverenyi NM
    Mol Psychiatry; 2001 Sep; 6(5):496, 529-39. PubMed ID: 11526467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
    Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
    Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.
    Hajek T; Bauer M; Pfennig A; Cullis J; Ploch J; O'Donovan C; Bohner G; Klingebiel R; Young LT; Macqueen GM; Alda M
    J Psychiatry Neurosci; 2012 May; 37(3):185-92. PubMed ID: 22353634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder.
    Bertolino A; Sciota D; Brudaglio F; Altamura M; Blasi G; Bellomo A; Antonucci N; Callicott JH; Goldberg TE; Scarabino T; Weinberger DR; Nardini M
    Am J Psychiatry; 2003 Mar; 160(3):483-9. PubMed ID: 12611829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
    Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
    Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
    Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.
    Gan JL; Cheng ZX; Duan HF; Yang JM; Zhu XQ; Gao CY
    Psychiatry Res; 2014 Jul; 223(1):23-7. PubMed ID: 24831926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia.
    Bertolino A; Esposito G; Callicott JH; Mattay VS; Van Horn JD; Frank JA; Berman KF; Weinberger DR
    Am J Psychiatry; 2000 Jan; 157(1):26-33. PubMed ID: 10618009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex.
    Marenco S; Steele SU; Egan MF; Goldberg TE; Straub RE; Sharrief AZ; Weinberger DR
    Am J Psychiatry; 2006 Apr; 163(4):740-2. PubMed ID: 16585454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional neuroimaging abnormalities in youth with psychosis spectrum symptoms.
    Wolf DH; Satterthwaite TD; Calkins ME; Ruparel K; Elliott MA; Hopson RD; Jackson CT; Prabhakaran K; Bilker WB; Hakonarson H; Gur RC; Gur RE
    JAMA Psychiatry; 2015 May; 72(5):456-65. PubMed ID: 25785510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
    Bertolino A; Caforio G; Blasi G; De Candia M; Latorre V; Petruzzella V; Altamura M; Nappi G; Papa S; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
    Am J Psychiatry; 2004 Oct; 161(10):1798-805. PubMed ID: 15465976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
    Egan MF; Straub RE; Goldberg TE; Yakub I; Callicott JH; Hariri AR; Mattay VS; Bertolino A; Hyde TM; Shannon-Weickert C; Akil M; Crook J; Vakkalanka RK; Balkissoon R; Gibbs RA; Kleinman JE; Weinberger DR
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12604-9. PubMed ID: 15310849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.